Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II

References

1. Banerjee A., Dubnau E., Quemard A., Balasubramanian V., Um K. S., Wilson T., Collins D., de Lisle G., Jacobs W. R. Jr 1994; inhA , a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis . Science 263:227–230
   [Google Scholar]
2. Banerjee A., Sugantino M., Sacchettini J. C., Jacobs W. R. Jr 1998; The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology 144:2697–2704
   [Google Scholar]
3. Belanger A. E., Besra G. S., Ford M. E., Mikusova K., Belisle J. T., Brennan P. J., Inamine J. M. 1996; The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci U S A 93:11919–11924
   [Google Scholar]
4. Brennan P. J., Nikaido H. 1995; The envelope of mycobacteria. Annu Rev Biochem 64:29–63
   [Google Scholar]
5. Brown A. K., Sridharan S., Kremer L., Lindenberg S., Dover L. G., Sacchettini J. C., Besra G. S. 2005; Probing the mechanism of the Mycobacterium tuberculosis β -ketoacyl-acyl carrier protein synthase III mt FabH: factors influencing catalysis and substrate specificity. J Biol Chem 280:32539–32547
   [Google Scholar]
6. Castell A., Johansson P., Unge T., Jones T. A., Backbro K. 2005; Rv0216, a conserved hypothetical protein from Mycobacterium tuberculosis that is essential for bacterial survival during infection, has a double hotdog fold. Protein Sci 14:1850–1862
   [Google Scholar]
7. Centers for Disease Control and Prevention; 2006; Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs – worldwide, 2000–2004. MMWR Morb Mortal Wkly Rep 55:301–305
   [Google Scholar]
8. Cole S. T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S. V., Eiglmeier K., Gas S. other authors 1998; Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393:537–544
   [Google Scholar]
9. Cos P., Ying L., Calomme M., Hu J. P., Cimanga K., Van Poel B., Pieters L., Vlietinck A. J., Vanden Berghe D. 1998; Structure–activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers. J Nat Prod 61:71–76
   [Google Scholar]
10. Dover L. G., Cerdeno-Tarraga A. M., Pallen M. J., Parkhill J., Besra G. S. 2004; Comparative cell wall core biosynthesis in the mycolated pathogens, Mycobacterium tuberculosis and Corynebacterium diphtheriae . FEMS Microbiol Rev 28:225–250
    [Google Scholar]
11. Dover L. G., Alahari A., Gratraud P., Gomes J. M., Bhowruth V., Reynolds R. C., Besra G. S., Kremer L. 2007; EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets. Antimicrob Agents Chemother 51:1055–1063
    [Google Scholar]
12. Dye C. 2006; Global epidemiology of tuberculosis. Lancet 367:938–940
    [Google Scholar]
13. Eiglmeier K., Parkhill J., Honore N., Garnier T., Tekaia F., Telenti A., Klatser P., James K. D., Thomson N. R. other authors 2001; The decaying genome of Mycobacterium leprae . Lepr Rev 72:387–398
    [Google Scholar]
14. Franzblau S. G., Witzig R. S., McLaughlin J. C., Torres P., Madico G., Hernandez A., Degnan M. T., Cook M. B., Quenzer V. K. other authors 1998; Rapid, low-technology MIC determination with clinical Mycobacterium tuberculosis isolates by using the microplate Alamar Blue assay. J Clin Microbiol 36:362–366
    [Google Scholar]
15. Fukui T., Doi Y. 1997; Cloning and analysis of the poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) biosynthesis genes of Aeromonas caviae . J Bacteriol 179:4821–4830
    [Google Scholar]
16. Gande R., Gibson K. J., Brown A. K., Krumbach K., Dover L. G., Sahm H., Shioyama S., Oikawa T., Besra G. S., Eggeling L. 2004; Acyl-CoA carboxylases ( accD2 and accD3 ), together with a unique polyketide synthase (Cg-pks), are key to mycolic acid biosynthesis in Corynebacterianeae such as Corynebacterium glutamicum and Mycobacterium tuberculosis . J Biol Chem 279:44847–44857
    [Google Scholar]
17. Harborne J. B., Williams C. A. 2000; Advances in flavonoid research since 1992. Phytochemistry 55:481–504
    [Google Scholar]
18. Hisano T., Tsuge T., Fukui T., Iwata T., Miki K., Doi Y. 2003; Crystal structure of the ( R )-specific enoyl-CoA hydratase from Aeromonas caviae involved in polyhydroxyalkanoate biosynthesis. J Biol Chem 278:617–624
    [Google Scholar]
19. Kaye K., Frieden T. R. 1996; Tuberculosis control: the relevance of classic principles in an era of acquired immunodeficiency syndrome and multidrug resistance. Epidemiol Rev 18:52–63
    [Google Scholar]
20. Kikuchi S., Kusaka T. 1984; Purification of NADPH-dependent enoyl-CoA reductase involved in the malonyl-CoA dependent fatty acid elongation system of Mycobacterium smegmatis . J Biochem (Tokyo 96:841–848
    [Google Scholar]
21. Koes R. E., Quattrocchio F., Mol J. N. M. 1994; The flavonoid biosynthetic pathway in plants – function and evolution. Bioessays 16:123–132
    [Google Scholar]
22. Kremer L., Baulard A., Estaquier J., Content J., Capron A., Locht C. 1995; Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J Bacteriol 177:642–653
    [Google Scholar]
23. Kremer L., Douglas J. D., Baulard A. R., Morehouse C., Guy M. R., Alland D., Dover L. G., Lakey J. H., Jacobs W. R. other authors 2000; Thiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis . J Biol Chem 275:16857–16864
    [Google Scholar]
24. Kremer L., Nampoothiri K. M., Lesjean S., Dover L. G., Graham S., Betts J., Brennan P. J., Minnikin D. E., Locht C., Besra G. S. other authors 2001; Biochemical characterization of acyl carrier protein (AcpM) and malonyl-CoA : AcpM transacylase (mtFabD), two major components of Mycobacterium tuberculosis fatty acid synthase II. J Biol Chem 276:27967–27974
    [Google Scholar]
25. Kremer L., Dover L. G., Carrere S., Nampoothiri K. M., Lesjean S., Brown A. K., Brennan P. J., Minnikin D. E., Locht C., Besra G. S. other authors 2002; Mycolic acid biosynthesis and enzymic characterization of the beta-ketoacyl-ACP synthase A-condensing enzyme from Mycobacterium tuberculosis . Biochem J 364:423–430
    [Google Scholar]
26. Larsen M. H., Vilcheze C., Kremer L., Besra G. S., Parsons L., Salfinger M., Heifets L., Hazbon M. H., Alland D. other authors 2002; Overexpression of inhA , but not kasA , confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis , M. bovis BCG and M. tuberculosis . Mol Microbiol 46:453–466
    [Google Scholar]
27. Lea-Smith D. J., Pyke J. S., Tull D., McConville M. J., Coppel R. L., Crellin P. K. 2007; The reductase that catalyzes mycolic motif synthesis is required for efficient attachment of mycolic acids to arabinogalactan. J Biol Chem 282:11000–11008
    [Google Scholar]
28. Li B. H., Tian W. X. 2004; Inhibitory effects of flavonoids on animal fatty acid synthase. J Biochem (Tokyo 135:85–91
    [Google Scholar]
29. Li X. C., Joshi A. S., ElSohly H. N., Khan S. I., Jacob M. R., Zhang Z., Khan I. A., Ferreira D., Walker L. A. other authors 2002; Fatty acid synthase inhibitors from plants: isolation, structure elucidation, and SAR studies. J Nat Prod 65:1909–1914
    [Google Scholar]
30. Mdluli K., Slayden R. A., Zhu Y., Ramaswamy S., Pan X., Mead D., Crane D. D., Musser J. M., Barry C. E. III 1998; Inhibition of a Mycobacterium tuberculosis β -ketoacyl ACP synthase by isoniazid. Science 280:1607–1610
    [Google Scholar]
31. Paolo W. F. Jr, Nosanchuk J. D. 2004; Tuberculosis in New York city: recent lessons and a look ahead. Lancet Infect Dis 4:287–293
    [Google Scholar]
32. Portevin D., de Sousa-D'Auria C., Montrozier H., Houssin C., Stella A., Laneelle M. A., Bardou F., Guilhot C., Daffe M. 2005; The acyl-AMP ligase FadD32 and AccD4-containing acyl-CoA carboxylase are required for the synthesis of mycolic acids and essential for mycobacterial growth: identification of the carboxylation product and determination of the acyl-CoA carboxylase components. J Biol Chem 280:8862–8874
    [Google Scholar]
33. Qin Y. M., Haapalainen A. M., Kilpelainen S. H., Marttila M. S., Koski M. K., Glumoff T., Novikov D. K., Hiltunen J. K. 2000; Human peroxisomal multifunctional enzyme type 2. Site-directed mutagenesis studies show the importance of two protic residues for 2-enoyl-CoA hydratase 2 activity. J Biol Chem 275:4965–4972
    [Google Scholar]
34. Radmacher E., Alderwick L. J., Besra G. S., Brown A. K., Gibson K. J. C., Sahm H., Eggeling L. 2005; Two functional FAS-I type fatty acid synthases in Corynebacterium glutamicum . Microbiology 151:2421–2427
    [Google Scholar]
35. Sambrook J., Russell D. W. 2001 Molecular Cloning: A Laboratory Manual , 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
36. Sassetti C. M., Boyd D. H., Rubin E. J. 2003; Genes required for mycobacterial growth defined by high density mutagenesis. Mol Microbiol 48:77–84
    [Google Scholar]
37. Sauton B. 1912; Sur la nutrition minérale du bacille tuberculeux. C R Hebd Seances Acad Sci 155:860–861
    [Google Scholar]
38. Schaeffer M. L., Agnihotri G., Volker C., Kallender H., Brennan P. J., Lonsdale J. T. 2001; Purification and biochemical characterization of the Mycobacterium tuberculosis β -ketoacyl-acyl carrier protein synthases KasA and KasB. J Biol Chem 276:47029–47037
    [Google Scholar]
39. Sharma S. K., Parasuraman P., Kumar G., Surolia N., Surolia A. 2007; Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR. J Med Chem 50:765–775
    [Google Scholar]
40. Slayden R. A., Lee R. E., Armour J. W., Cooper A. M., Orme I. M., Brennan P. J., Besra G. S. 1996; Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis. Antimicrob Agents Chemother 40:2813–2819
    [Google Scholar]
41. Smith S., Witkowski A., Joshi A. K. 2003; Structural and functional organization of the animal fatty acid synthase. Prog Lipid Res 42:289–317
    [Google Scholar]
42. Takayama K., Wang C., Besra G. S. 2005; Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis . Clin Microbiol Rev 18:81–101
    [Google Scholar]
43. Tasdemir D., Lack G., Brun R., Ruedi P., Scapozza L., Perozzo R. 2006; Inhibition of Plasmodium falciparum fatty acid biosynthesis: evaluation of FabG, FabZ, and FabI as drug targets for flavonoids. J Med Chem 49:3345–3353
    [Google Scholar]
44. Vissa V. D., Brennan P. J. 2001; The genome of Mycobacterium leprae : a minimal mycobacterial gene set. Genome Biol 2:1–7
    [Google Scholar]
45. Wang X., Song K. S., Guo Q. X., Tian W. X. 2003; The galloyl moiety of green tea catechins is the critical structural feature to inhibit fatty-acid synthase. Biochem Pharmacol 66:2039–2047
    [Google Scholar]
46. Zhang Y. M., Rock C. O. 2004; Evaluation of epigallocatechin gallate and related plant polyphenols as inhibitors of the FabG and FabI reductases of bacterial type II fatty-acid synthase. J Biol Chem 279:30994–31001
    [Google Scholar]